« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6
, Pages 1352-1354.e7
, December 2009
Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis
References
- Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114:S155–S212
- . Pediatric sinusitis is not a surgical disease. Ear Nose Throat J. 1992;71:622–623
- Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol. 2003;111:342–349
- . Evolution of symptoms associated to nasal polyposis following oral steroid treatment and nasalization of the ethmoid-radical ethmoidectomy is functional surgery for NPS. Rhinology. 2003;41:211–219
- . The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2006;126:606–612
- . Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;18:CD006394
- . National Asthma Education and Prevention Program Expert Panel report 3: guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institutes of Health; 2007;
- . Clinical and symptom criteria for the accurate diagnosis of chronic rhinosinusitis. Laryngoscope. 2006;116:1–22
- . Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med. 2000;161:2051–2057
Supported by National Institutes of Health grant nos. RO1 AI01793 and PO1 AI50989. Disclosure of potential conflict of interest: J. W. Steinke has received research support from the National Institutes of Health. S. C. Payne has received honoraria from Acclarent, Inc, has received research support from the American Academy of Otolaryngologic Allergy, and has provided legal consultation or expert witness testimony on the topic of tonsillectomies. L. C. Borish is on the speakers' bureau for Merck, is on an advisory board for Genentech and Novartis, and has received research support from Genentech and Merck. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(09)01406-7
doi: 10.1016/j.jaci.2009.09.018
© 2009 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6
, Pages 1352-1354.e7
, December 2009
